John Brownstein runs innovation at Boston Children's Hospital. He's deploying OpenAI's new healthcare product across his organization. He's also predicting it will hurt someone.
"I'm worried about the potential of an AI adverse event that could set the whole field back," Brownstein told Bloomberg this week. Then the admission. "I think it's very likely we'll see it."
That sentence should stop you. A senior executive at one of America's top pediatric hospitals, signing contracts with OpenAI while publicly acknowledging the technology will probably cause harm. Not might. Will. He's betting the benefits outweigh the casualties. Parents bringing their kids to Boston Children's didn't get a vote on that bet.
This article continues below.
Sign up once, read everything for free. No algorithms, no fluff—just the AI intel that actually matters for your work.
Get free access →
